Novocastra™ - NCL-SPEC1 is intended for the qualitative - LEICA BIOSYSTEMS NEWCASTLE LTD

Duns Number:397134693

Device Description: NCL-SPEC1 is intended for the qualitative identification by light microscopy of Spectrin b NCL-SPEC1 is intended for the qualitative identification by light microscopy of Spectrin by immunohistochemistry.

Want to know more about this Product? Request more information now!


More Product Details

Catalog Number

NCL-SPEC1

Brand Name

Novocastra™

Version/Model Number

SPEC1-CE

Device Commercial Distribution Status

Not in Commercial Distribution

Commercial Distribution End Date

June 30, 2021

Issuing Agency

In GS1

Product Characteristics

MRI safety Status

Labeling does not contain MRI Safety Information

Device required to be labeled as containing natural rubber latex or dry natural rubber (21 CFR 801.437)

-

Device labeled as "Not made with natural rubber latex"

-

For Single-Use

-

Prescription Use (Rx)

Yes

Over the Counter (OTC)

-

Kit

-

Combination Product

-

Human Cell, Tissue or Cellular or Tissue-Based Product (HCT/P)

-

FDA Premarket Submission

-

Product Code Details

Product Code

NJT

Product Code Name

Immunohistochemistry Reagents And Kits

Device Record Status

Public Device Record Key

5904ce02-4b17-4b79-90a8-3d10582f821b

Public Version Date

July 01, 2021

Public Version Number

2

DI Record Publish Date

March 12, 2021

Additional Identifiers

Package DI Number

None

Quantity per Package

-

Contains DI Package

-

Package Discontinue Date

-

Package Status

-

Package Type

-

"LEICA BIOSYSTEMS NEWCASTLE LTD" Characteristics
Device Class Device Class Description No of Devices
1 A medical device with low to moderate risk that requires general controls 365
2 A medical device with a moderate to high risk that requires special controls. 7
3 A medical device with high risk that requires premarket approval 1